Clinical Trials Browser

Phase 1/2 × Neoplasm Metastasis × Pharmaceutical Preparations × Clear all

NCT04138381 2023-03-27

SeliGIST

Phase 1/2 Unknown

Neoplasm Metastasis, Sarcoma, Drug-Related Side Effects and Adverse Reactions